JPWO2023237484A5 - - Google Patents

Info

Publication number
JPWO2023237484A5
JPWO2023237484A5 JP2024570947A JP2024570947A JPWO2023237484A5 JP WO2023237484 A5 JPWO2023237484 A5 JP WO2023237484A5 JP 2024570947 A JP2024570947 A JP 2024570947A JP 2024570947 A JP2024570947 A JP 2024570947A JP WO2023237484 A5 JPWO2023237484 A5 JP WO2023237484A5
Authority
JP
Japan
Prior art keywords
methylene
freeze
tetrahydrofolic acid
disodium salt
citrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024570947A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025518274A5 (https=
JP2025518274A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/064972 external-priority patent/WO2023237484A1/en
Publication of JP2025518274A publication Critical patent/JP2025518274A/ja
Publication of JPWO2023237484A5 publication Critical patent/JPWO2023237484A5/ja
Publication of JP2025518274A5 publication Critical patent/JP2025518274A5/ja
Pending legal-status Critical Current

Links

JP2024570947A 2022-06-08 2023-06-05 5,10-メチレン-(6r)-テトラヒドロ葉酸二ナトリウムを含む組成物 Pending JP2025518274A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22177932 2022-06-08
EP22177932.5 2022-06-08
PCT/EP2023/064972 WO2023237484A1 (en) 2022-06-08 2023-06-05 Compositions comprising disodium 5,10-methylene-(6r)-tetrahydrofolate

Publications (3)

Publication Number Publication Date
JP2025518274A JP2025518274A (ja) 2025-06-12
JPWO2023237484A5 true JPWO2023237484A5 (https=) 2025-12-18
JP2025518274A5 JP2025518274A5 (https=) 2025-12-18

Family

ID=81984853

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024570947A Pending JP2025518274A (ja) 2022-06-08 2023-06-05 5,10-メチレン-(6r)-テトラヒドロ葉酸二ナトリウムを含む組成物

Country Status (9)

Country Link
US (1) US20250360135A1 (https=)
EP (2) EP4536187B1 (https=)
JP (1) JP2025518274A (https=)
KR (1) KR20250022145A (https=)
CN (1) CN119365186A (https=)
AU (1) AU2023282347A1 (https=)
CA (1) CA3258734A1 (https=)
IL (1) IL317395A (https=)
WO (1) WO2023237484A1 (https=)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1215945A (en) 1983-03-20 1986-12-30 Bengt Gustavsson Fluid transfer system
CH682664A5 (en) * 1991-10-15 1993-10-29 Eprova Ag Stable salts of 5,10-methylene tetrahydrofolate.
CN1122456C (zh) * 1996-01-31 2003-10-01 南亚拉巴马医学科学基金会 含有天然的还原叶酸盐异构体的食品和维生素制品
CH696628A5 (de) * 2002-02-26 2007-08-31 Eprova Ag Verwendung von Folaten zur Herstellung einer Zubereitung geeignet zur Vorbeugung und Behandlung von Entzündungen und entzündungsassoziierter Krankheiten, im Speziellen zur Beeinflussung der
CH697021A5 (de) * 2003-06-26 2008-03-31 Merck Eprova Ag Stabile pharmazeutische Zusammensetzungen von 5, 10-Methylentetrahydrofolat.
EP1968551A2 (en) 2005-12-02 2008-09-17 Adventrx Pharmaceuticals, Inc. Stable pharmaceutical compositions of 5,10 methylenetetrahydrofolate
JP6235779B2 (ja) * 2012-03-28 2017-11-22 株式会社コーセー 葉酸含有組成物及び葉酸の安定化方法
EP2799061A1 (en) * 2013-04-30 2014-11-05 Aprofol AG Stable high dose pharmaceutical composition containing folates
EP2837631A1 (en) * 2013-08-14 2015-02-18 Merck & Cie New stable salt of 5,10-methylene-(6R)-tetrahydrofolic acid
US10059710B2 (en) * 2016-02-17 2018-08-28 Merck & Cie Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
DK3668516T3 (da) 2017-08-16 2021-12-13 Merck Patent Gmbh Stabile lyofilisater omfattende 5,10-methylen-(6r)-tetrahydrofolsyre og en dicarboxylsyre
CN107892692A (zh) * 2017-12-28 2018-04-10 华东理工大学 (6s)‑5‑甲基四氢叶酸锌盐的制备方法及其应用

Similar Documents

Publication Publication Date Title
US4126680A (en) Tetracycline antibiotic compositions
JPH0356418A (ja) 冷蔵庫温度で安定なホリニン酸塩水溶液並びにその製造方法
JP2013529201A5 (https=)
RU2012147527A (ru) Тетрациклиновая композиция
AU2023258405B2 (en) Folate salts for medical use
EP1372676A1 (en) Pharmaceutical composition comprising copper, salicylic acid, vitamin c and zinc for use in treatment of different diseases such as bacterial or viral infection
JP2004067682A (ja) 抗生物質活性を有する薬学的組成物
KR100812693B1 (ko) 항종양 효과 증강제 및 항종양제
RU2008146217A (ru) Фармацевтическая композиция, содержащая производное таксана, которая предназначена для приготовления инфузионного раствора, способ его приготовления и использование
JP2003530431A (ja) ナフタルイミドおよび抗増殖性剤を含有する組成物
JP2026041939A (ja) 葉酸塩
JPS605567B2 (ja) オキシテトラサイクリンの調合液
JPWO2023237484A5 (https=)
JPH09502709A (ja) エストロン誘導体及びカルシウム塩含有の経口、水溶性製薬組成物
JPH09510989A (ja) 安定なフォリン酸塩水溶液
IL317395A (en) Compositions containing disodium 10,5-methylene-(6R)-tetrahydrofolate
US5075295A (en) Novel oxytetracycline compositions
JPH10338638A (ja) 損傷皮膚修復用製剤
JPH07215868A (ja) 細胞内グルタチオンを刺激する方法及び組成物
JP3122921B2 (ja) ビオチン含有内用液剤
JPH06505749A (ja) 1,4−置換ピペリジンの誘導体に基づく新規液体組成物
JP2000044469A (ja) 内服液剤
US20040092592A1 (en) Stabilized L-Arginine platelet aggregation inhibitory compositions and processes for making same
JPWO1997030706A1 (ja) 抗腫瘍剤含有組成物
US20100267824A1 (en) Stable oxaliplatin composition for parenteral administration